The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6-hydroxydopamine microinjection in the substantia nigra

Acta Physiologica

Volumn 211, Issue 2, 2014, Pages 434-446

  Zheng, L F ^a   Song, J ^a   Fan, R F ^a   Chen, C L ^a   Ren, Q Z ^a   Zhang, X L ^a   Feng, X Y ^a   Zhang, Y ^a   Li, L S ^a   Zhu, J X ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Domperidone; Myenteric plexus; Tyrosine hydroxylase; Vagotomy

Indexed keywords

DOMPERIDONE; DOPAMINE; DOPAMINE RECEPTOR; LACTIC ACID; NORADRENALIN; OXIDOPAMINE; VASOACTIVE INTESTINAL POLYPEPTIDE; ACETYLCHOLINE; ADRENERGIC RECEPTOR BLOCKING AGENT;

ABDOMINAL WALL MUSCULATURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; EXTERNAL JUGULAR VEIN; FOOD INTAKE; GASTRIC DYSMOTILITY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MICROINJECTION; MYENTERIC PLEXUS; NISSL STAINING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOGRAPHY; RADIOIMMUNOASSAY; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH EMPTYING; STOMACH MOTILITY; STOMACH MUSCLE; STOMACH PARESIS; STOMACH WALL; STRAIN GAUGE TRANSDUCER; SUBSTANTIA NIGRA; TISSUE PREPARATION; VAGOTOMY; VAGUS NERVE; WESTERN BLOTTING; ANIMAL; CHEMISTRY; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; GASTROINTESTINAL MOTILITY; GASTROPARESIS; METABOLISM; PARKINSONISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; STOMACH; TOXICITY;

ACETYLCHOLINE; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; DOPAMINE; FLUORESCENT ANTIBODY TECHNIQUE; GASTROINTESTINAL MOTILITY; GASTROPARESIS; MALE; OXIDOPAMINE; PARKINSONIAN DISORDERS; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; STOMACH; SUBSTANTIA NIGRA; SYMPATHOLYTICS; VAGUS NERVE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84900528499     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12229     Document Type: Article

References (40)

1. Anderson, G., Noorian, A.R., Taylor, G., Anitha, M., Bernhard, D., Srinivasan, S. & Greene, J.G. 2007. Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease. Exp Neurol 207, 4-12.
2. Anlauf, M., Schafer, M.K., Eiden, L. & Weihe, E. 2003. Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes. J Comp Neurol 459, 90-111.
3. Annerino, D.M., Arshad, S., Taylor, G.M., Adler, C.H., Beach, T.G. & Greene, J.G. 2012. Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol 124, 665-680.
4. Braak, H., de Vos, R.A., Bohl, J. & Tredici, K.D. 2006. Gastric alpha-synuclein immunoreactive includsion in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 396, 67-72.
5. Cai, Q.Q., Zheng, L.F., Fan, R.F., Lian, H., Zhou, L., Song, H.Y., Tang, Y.Y., Feng, X.Y., Guo, Z.K., Wang, Z.Y. & Zhu, J.X. 2013. Distribution of dopamine receptors D(1)- and D(2)-immunoreactive neurons in the dorsal motor nucleus of vagus in rats. Auton Neurosci 176, 48-53.
6. Code, C.F. & Marlett, J.A. 1975. The interdigestive myo-electric complex of the stomach and small bowel of dogs. J Physiol 246, 289-309.
7. Colucci, M., Cervio, M., Faniglione, M., De Angelis, S., Pajoro, M., Levandis, G., Tassorelli, C., Blandini, F., Feletti, F., De Giorgio, R., Dellabianca, A., Tonini, S. & Tonini, M. 2012. Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model. Auton Neurosci 169, 77-86.
8. Dent, J. 1983. Interdigestive phasic contractions of the human lower esophageal sphincter. Gastroenterology 84, 453-460.
9. 2), alpha and beta-adrenoceptor receptors in the decrease in gastrointestinal transit induced by dopamine and dopamine-related drugs in the rat. Pharmacol Res 27, 335-347.
10. Eisenhofer, G., Aneman, A., Friberg, P., Hooper, D., Fandriks, L., Lonroth, H., Hunyady, B. & Mezey, E. 1997. Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab 82, 3864-3871.
11. Ferro, M.M., Bellissimo, M.I., Anselmo-Franci, J.A., Angellucci, M.E., Canteras, N.S. & Da Cunha, C. 2005. Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations. J Neurosci Methods 148, 78-87.
12. Garella, R. & Baccari, M.C. 2012. Endocannabinoids modulate non-adrenergic, non-cholinergic inhibitory neurotransmission in strips from the mouse gastric fundus. Acta Physiol (Oxf) 206, 80-87.
13. Gibbons, S.J. & Farrugia, G. 2004. The role of carbon monoxide in the gastrointestinal tract. J Physiol 556, 325-336.
14. Goetze, O., Wieczorek, J., Mueller, T., Przuntek, H., Schmidt, W.E. & Woitalla, D. 2005. Impaired gastric emptying of a solid test meal in patients with Parkinson's disease using 13C-sodium octanoate breath test. Neurosci Lett 375, 170-173.
15. Goetze, O., Nikodem, A.B., Wiezcorek, J., Banasch, M., Przuntek, H., Mueller, T., Schmidt, W.E. & Woitalla, D. 2006. Predictors of gastric emptying in Parkinson's disease. Neurogastroenterol Motil 18, 369-375.
16. Greene, J.G., Noorian, A.R. & Srinivasan, S. 2009. Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease. Exp Neurol 218, 154-161.
17. Hardoff, R., Soil, A., Front, A., Badarna, S., Honigman, S. & Giladi, N. 2001. Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov Disord 16, 1041-1047.
18. Heetun, Z.S. & Quigley, E.M. 2012. Gastroparesis and Parkinson's disease: a systematic review. Parkinsonism Relat Disord 18, 433-440.
19. Jost, W.H. 2010. Gastrointestinal dysfunction in Parkinson's Disease. J Neurol Sci 289, 69-73.
20. Kalaitzakis, M.E., Graeber, M.B., Gentleman, S.M. & Pearce, R.K. 2008. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein staging. Neuropathol Appl Neurobiol 34, 284-295.
21. Kirschstein, T., Dammann, F., Klostermann, J., Rehberg, M., Tokay, T., Schubert, R. & Köhling, R. 2009. Dopamine induces contraction in the proximal, but relaxation in the distal rat isolated small intestine. Neurosci Lett 465, 21-26.
22. Krygowska-Wajs, A., Lorens, K., Thor, P., Szczudlik, A. & Konturek, S. 2000. Gastric electromechanical dysfunction in Parkinson's disease. Funct Neurol 15, 41-46.
23. Kusunoki, M., Taniyama, K. & Tanaka, C. 1985. Dopamine regulation of [3H]acetylcholine release from guinea-pig stomach. J Pharmacol Exp Ther 234, 713-719.
24. Lefebvre, R., Willems, J. & Bogaert, M. 1984. In vitro study of the influence of dopamine on rat and dog gastric fundus. Scand J Gastroenterol Suppl 89, 55-58.
25. Li, Z.S., Pham, T.D., Tamir, H., Chen, J.J. & Gershon, M.D. 2004. Enteric dopaminergic neurons: definition, developmental lineage, and effects of extrinsic denervation. J Neurosci 24, 1330-1339.
26. 2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice. J Neurosci 26, 2798-2807.
27. Melamed, E., Zoldan, J., Galili-Mosberg, R., Ziv, I. & Djaldetti, R. 1999. Current management of motor fluctuations in patients with advanced Parkinson's disease treated chronically with levodopa. J Neural Transm Suppl 56, 173-183.
28. Natale, G., Kastsiushenka, O., Fulceri, F., Ruggieri, S., Paparelli, A. & Fornai, F. 2010. MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut. Brain Res 1355, 195-206.
29. Persson, P.B. & Henriksson, J. 2011. Good publication practise in physiology. Acta Physiol 203, 403-407.
30. Pfeiffer, R.F. 2011. Gastrointestinal dysfunction in Parkinson's disease. Parkinsonism Relat Disord 17, 10-15.
31. Schuurkes, J.A. & Van Nueten, J.M. 1984a. Control of gastroduodenal coordination: dopaminergic and cholinergic pathways. Scand J Gastroenterol Suppl 92, 8-12.
32. Schuurkes, J.A. & Van Nueten, J.M. 1984b. Domperidone improves myogenically transmitted antroduodenal coordination by blocking dopaminergic receptor sites. Scand J Gastroenterol Suppl 96, 101-110.
33. Shichijo, K., Sakurai-Yamashita, Y., Sekine, I. & Taniyama, K. 1997. Neuronal release of endogenous dopamine from corpus of guinea pig stomach. Am J Physiol 273, G1044-G1050.
34. Takahashi, T., Kurosawa, S., Wiley, J.W. & Owyang, C. 1991. Mechanism for the gastrokinetic action of domperidone In vitro studies in guinea pigs. Gastroenterology 101, 703-710.
35. Tanaka, T., VanKlompenberg, L.H. & Sarr, M.G. 2001. Selective role of vagal and nonvagal innervation in initiation and coordination of gastric and small bowel patterns of interdigestive and postprandial motility. J Gastrointest Surg 5, 418-433.
36. Thomaides, T., Karapanayiotides, T., Zoukos, Y., Haeropoulos, C., Kerezoudi, E., Demacopoulos, N., Floodas, G., Papageorgiou, E., Armakola, F., Thomopoulos, Y. & Zaloni, I. 2005. Gastric emptying after semi-solid food in multiple system atrophy and Parkinson disease. J Neurol 252, 1055-1059.
37. Tian, Y.M., Chen, X., Luo, D.Z., Zhang, X.H., Xue, H., Zheng, L.F., Yang, N., Wang, X.M. & Zhu, J.X. 2008. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease. Neuroscience 153, 634-644.
38. Walker, J.K., Gainetdinov, R.R., Mangel, A.W., Caron, M.G. & Shetzline, M.A. 2000. Mice lacking the dopamine transporter display altered regulation of distal colonic motility. Am J Physiol Gastrointest Liver Physiol 279, G311-G318.
39. 1 mediates the inhibition of dopamine on the distal colonic motility. Transl Res 159, 407-414.
40. Zheng, L.F., Wang, Z.Y., Li, X.F., Song, J., Hong, F., Lian, H., Wang, Q., Feng, X.Y., Tang, Y.Y., Zhang, Y. & Zhu, J.X. 2011. Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson's disease. Brain Res 1420, 59-67.